ICD-10 Coding for Adenocarcinoma Lung Cancer(C34.0, C34.11, C34.11B)
Comprehensive guide to ICD-10 coding for adenocarcinoma lung cancer, including primary and metastatic codes, documentation requirements, and common pitfalls.
Complete code families applicable to Adenocarcinoma Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Use when adenocarcinoma is confirmed in the right upper lobe of the lung. |
|
| C78.01 | Secondary malignant neoplasm of right lung | Use when adenocarcinoma has metastasized to the right lung. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdenocarcinoma Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adenocarcinoma Lung Cancer.
Failing to specify the lobe of the lung affected by cancer.
Impact
Clinical: Impacts treatment decisions and surgical planning., Regulatory: Non-compliance with coding guidelines., Financial: Potential for reduced reimbursement.
Mitigation
Ensure imaging and pathology reports specify the affected lobe., Train staff on the importance of detailed documentation.
Using C34.9 for unspecified lung cancer without attempting histological confirmation.
Impact
Reimbursement: May lead to lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding standards., Data Quality: Decreases accuracy of cancer registry data.
Mitigation
Ensure histological confirmation is attempted and documented.
Histological Confirmation
Impact
Risk of audit if histological confirmation is not documented.
Mitigation
Ensure all diagnoses are supported by pathology reports.